Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
Title:
Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
Author:
Tonini, G. Bizzarri, C. Bonfanti, R. Vanelli, M. Cerutti, F. Faleschini, E. Meschi, F. Prisco, F. Ciacco, E. Cappa, M. Torelli, C. Cauvin, V. Tumini, S. Iafusco, D. Barbetti, F.